Histology
Carcinoma of Unknown Primary
CI-CAN-00002109Explore in graph →
4,156 active trials54 approved drugs532 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00002109Explore in graph →
Clinical trials
14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,893)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00629668 | Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease | unknown | N/A | — | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Mar 6, 2008 | clinicaltrials |
| NCT00001240 | Evaluating Patients With Abnormal Levels of Gastric Acid | completed | — | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 5, 2008 |
| clinicaltrials |
| NCT00059735 | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma | completed | Phase 2 | 30 | Eisai Inc.INDUSTRY | 2 | Mar 5, 2008 | clinicaltrials |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001442 | A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001603 | The Effects of Upper Airway and Digestive Tract Tumors on the Immune System | completed | — | 93 | National Institute on Deafness and Other Communication Disorders (NIDCD)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001683 | A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005910 | Laparoscopy to Remove Pancreatic Tumors (Insulinomas) | completed | N/A | 23 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00600522 | Alternative Surgical Policy for Central Liver Tumors | completed | — | 15 | University of MilanOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00082082 | A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | completed | Phase 2 | — | SciClone PharmaceuticalsINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site | terminated | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00056173 | Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 43 | Aptose Biosciences Inc.INDUSTRY | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00148655 | Educational Interventions for Patients With DCIS | completed | N/A | 120 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00417677 | A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma | terminated | Phase 1 / Phase 2 | 124 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00195299 | Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck | completed | — | 20 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 27, 2007 | clinicaltrials |
| NCT00165217 | Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | completed | Phase 2 | 37 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00388063 | Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 2 | 55 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00464295 | Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)(HCC-CAP) | completed | Phase 2 | 15 | Aga Khan UniversityOTHER | 1 | Dec 14, 2007 | clinicaltrials |
| NCT00122876 | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 25 | Light Sciences OncologyINDUSTRY | 3 | Dec 7, 2007 | clinicaltrials |
| NCT00131651 | ATN-161 in Advanced Renal Cell Cancer | terminated | Phase 2 | 36 | AttenuonINDUSTRY | 1 | Dec 6, 2007 | clinicaltrials |
| NCT00073112 | A Study of ABT-751 in Patients With Renal Cell Cancer | completed | Phase 2 | 60 | AbbottINDUSTRY | 2 | Nov 29, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00559351 | RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | terminated | Phase 3 | 84 | Ministry of Scientific Research and Information Technology, PolandOTHER_GOV | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00557713 | XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00554125 | Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00460681 | Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00352833 | Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma | completed | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | Oct 26, 2007 | clinicaltrials |
| NCT00539630 | TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN | completed | Phase 3 | 86 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00534664 | Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma(TheraBionic) | completed | Phase 1 / Phase 2 | 40 | University of Sao PauloOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00041626 | Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone | unknown | Phase 3 | — | Introgen TherapeuticsINDUSTRY | 1 | Sep 11, 2007 | clinicaltrials |
| NCT00073125 | Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 103 | AbbottINDUSTRY | 2 | Aug 15, 2007 | clinicaltrials |
| NCT00514332 | Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled Study | terminated | N/A | 70 | University Hospital, MontpellierOTHER | 0 | Aug 9, 2007 | clinicaltrials |
| NCT00116389 | Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | terminated | Phase 2 | 60 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00481299 | Insulin Resistance in Women With Prolactinoma | completed | — | 2,004 | Universidade Federal do Rio de JaneiroOTHER | 1 | Jun 1, 2007 | clinicaltrials |
| NCT00479050 | Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm(TACE-RFA) | completed | Phase 1 | 291 | Shandong UniversityOTHER | 0 | May 25, 2007 | clinicaltrials |
| NCT00474734 | Intravascular Ultrasound for Hepatocellular Carcinoma Staging | unknown | — | — | University Hospital, GenevaOTHER | 1 | May 17, 2007 | clinicaltrials |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | terminated | Phase 2 | 24 | Swedish Medical CenterOTHER | 1 | Apr 5, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00155103 | Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma | unknown | — | 1,600 | National Taiwan University HospitalOTHER | 1 | Mar 21, 2007 | clinicaltrials |
| NCT00134186 | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | completed | Phase 2 | 43 | Pharmacyclics LLC.INDUSTRY | 1 | Mar 5, 2007 | clinicaltrials |
| NCT00439127 | OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation | completed | — | 28 | Oncology Institute of Southern SwitzerlandOTHER | 0 | Feb 28, 2007 | clinicaltrials |
| NCT00426062 | Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva | unknown | — | — | Sheba Medical CenterOTHER_GOV | 1 | Feb 21, 2007 | clinicaltrials |
| NCT00191503 | Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma | completed | Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191750 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | completed | Phase 2 | 80 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00386984 | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | Phase 3 | 108 | University Hospital FreiburgOTHER | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00364715 | Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer | completed | — | — | National Taiwan University HospitalOTHER | 1 | Aug 17, 2006 | clinicaltrials |
| NCT00355212 | Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma | terminated | Phase 3 | 240 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00356161 | HAI Via Interventionally Implanted Port Catheter Systems | unknown | Phase 2 | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jul 25, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Mar 6, 2008source: clinicaltrials